Joseph Papa

Joseph Papa

President, Chief Executive Officer and DirectoratEmergent BioSolutions· In proxies 2023–2025

Pay in FY2025-9% from the year before

Joseph Papa was paid $5.3M in FY2025 (Dec), down 9%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Emergent BioSolutions proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Emergent BioSolutionsPublic company · 3 yr
    • President, Chief Executive Officer and Director2023 – Present · 3 yrNo stock prices for these years
  2. Candel TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years
  3. Milestone PharmaPublic company
    • Director? – PresentNo stock prices for these years
  4. Mirador TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years
  5. SparingVisionPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Boards1

  • Emergent BioSolutionsDirector · 1 yr on the boardNot independent—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?